About all

Pro banthine side effects. Pro-Banthine Side Effects: Comprehensive Guide to Propantheline Usage and Interactions

What are the common side effects of Pro-Banthine. How does propantheline interact with other medications. What precautions should be taken when using Pro-Banthine. What is the recommended dosage for propantheline.

Understanding Pro-Banthine: An Overview of Propantheline

Pro-Banthine, also known by its generic name propantheline, is an anticholinergic medication used to treat various gastrointestinal and urinary conditions. This drug works by blocking the action of acetylcholine, a neurotransmitter that affects muscle contractions in the digestive and urinary systems.

Propantheline is primarily prescribed for conditions such as:

  • Peptic ulcers
  • Irritable bowel syndrome (IBS)
  • Excessive stomach acid production
  • Overactive bladder
  • Excessive sweating (hyperhidrosis)

While Pro-Banthine can be effective in managing these conditions, it’s crucial to understand its potential side effects and interactions with other medications.

Common Side Effects of Pro-Banthine: What to Expect

Like all medications, Pro-Banthine can cause side effects. It’s important to be aware of these potential adverse reactions:

  • Dry mouth
  • Blurred vision
  • Constipation
  • Urinary retention
  • Decreased sweating
  • Increased heart rate
  • Dizziness
  • Drowsiness

Are these side effects severe or long-lasting? In most cases, these side effects are mild and temporary. However, if they persist or worsen, it’s essential to consult your healthcare provider.

Managing Side Effects

To minimize the impact of side effects, consider the following tips:

  1. Stay hydrated to combat dry mouth
  2. Use artificial tears for eye dryness
  3. Increase fiber intake to prevent constipation
  4. Avoid driving or operating machinery if experiencing dizziness or blurred vision

Propantheline Interactions: Navigating the Medication Maze

Pro-Banthine can interact with numerous medications, potentially altering their effectiveness or increasing the risk of side effects. Some notable interactions include:

Anticholinergic Medications

Combining Pro-Banthine with other anticholinergic drugs can lead to additive effects and increased risk of side effects. Examples include:

  • Atropine
  • Benztropine
  • Scopolamine
  • Certain antidepressants (e.g., amitriptyline, clomipramine)

Botulinum Toxin Products

Can Pro-Banthine interact with botulinum toxin treatments? Yes, using Pro-Banthine after receiving botulinum toxin injections may potentiate systemic anticholinergic effects. Healthcare providers should monitor patients closely in such cases.

Cholinergic Medications

Propantheline can counteract the effects of cholinergic drugs, such as:

  • Bethanechol
  • Carbachol
  • Pilocarpine

This interaction may reduce the effectiveness of these medications in treating conditions like glaucoma or urinary retention.

Dosage Guidelines: Optimizing Pro-Banthine Use

The appropriate dosage of Pro-Banthine varies depending on the condition being treated and individual patient factors. Generally, the recommended dosages are:

  • For peptic ulcers: 15 mg taken orally 3 times daily and at bedtime
  • For irritable bowel syndrome: 15 mg taken orally 3 times daily before meals and at bedtime
  • For excessive sweating: 15 to 30 mg taken orally 3 times daily and at bedtime

How should Pro-Banthine be taken? It’s typically recommended to take Pro-Banthine on an empty stomach, about 30 minutes before meals and at bedtime. However, always follow your healthcare provider’s specific instructions.

Special Populations

Dosage adjustments may be necessary for certain groups:

  • Elderly patients: Lower doses may be recommended due to increased sensitivity to anticholinergic effects
  • Patients with renal or hepatic impairment: Dose reduction may be necessary
  • Children: Dosage should be determined by a pediatrician based on weight and condition

Precautions and Warnings: Ensuring Safe Pro-Banthine Use

While Pro-Banthine can be an effective treatment for various conditions, certain precautions should be observed:

Contraindications

Pro-Banthine should not be used in patients with:

  • Myasthenia gravis
  • Glaucoma
  • Severe ulcerative colitis
  • Obstructive uropathy
  • Paralytic ileus

Cautions

Special care should be taken in patients with:

  • Prostatic hypertrophy
  • Autonomic neuropathy
  • Hepatic or renal disease
  • Hyperthyroidism
  • Coronary heart disease

Is it safe to use Pro-Banthine during pregnancy or breastfeeding? Limited data is available on the use of propantheline during pregnancy or lactation. It’s crucial to consult with a healthcare provider to weigh the potential risks and benefits in these situations.

Long-term Use of Pro-Banthine: Considerations and Monitoring

For patients using Pro-Banthine over extended periods, regular monitoring is essential to ensure continued safety and efficacy:

  • Periodic evaluation of symptoms and treatment response
  • Monitoring for potential long-term side effects
  • Regular eye examinations to check for increased intraocular pressure
  • Assessment of cognitive function, especially in elderly patients

How often should patients on long-term Pro-Banthine therapy be evaluated? It’s generally recommended to have follow-up appointments every 3 to 6 months, but the frequency may vary based on individual patient factors and healthcare provider recommendations.

Discontinuation

When stopping Pro-Banthine treatment, especially after long-term use, it’s important to follow these guidelines:

  1. Consult with your healthcare provider before discontinuing the medication
  2. Gradually taper the dose to minimize potential withdrawal symptoms
  3. Monitor for the return of original symptoms
  4. Be prepared to adjust treatment if necessary

Alternatives to Pro-Banthine: Exploring Other Treatment Options

While Pro-Banthine can be effective for many patients, alternative treatments may be considered in some cases:

For Peptic Ulcers and Excessive Stomach Acid

  • Proton pump inhibitors (e.g., omeprazole, esomeprazole)
  • H2 receptor antagonists (e.g., ranitidine, famotidine)
  • Antacids
  • Helicobacter pylori eradication therapy (if applicable)

For Irritable Bowel Syndrome

  • Antispasmodics (e.g., dicyclomine, hyoscyamine)
  • Antidepressants (e.g., SSRIs, TCAs)
  • Probiotics
  • Dietary modifications and stress management techniques

For Overactive Bladder

  • Other anticholinergics (e.g., oxybutynin, tolterodine)
  • Beta-3 adrenergic agonists (e.g., mirabegron)
  • Botulinum toxin injections
  • Pelvic floor exercises

How do these alternatives compare to Pro-Banthine in terms of efficacy and side effects? The choice of treatment depends on various factors, including the specific condition, patient characteristics, and individual response to therapy. Your healthcare provider can help determine the most appropriate option based on your unique situation.

Pro-Banthine in Special Populations: Tailoring Treatment

Certain patient groups may require special considerations when using Pro-Banthine:

Elderly Patients

Older adults may be more susceptible to anticholinergic side effects, such as:

  • Confusion
  • Memory impairment
  • Falls
  • Urinary retention

Careful monitoring and potential dose adjustments are crucial in this population.

Pediatric Patients

While Pro-Banthine can be used in children, special care must be taken:

  • Dosage should be carefully calculated based on weight
  • Close monitoring for side effects is essential
  • Alternative treatments may be preferred in some cases

Patients with Comorbidities

Individuals with certain health conditions may require additional precautions:

  • Cardiovascular disease: Monitor for potential effects on heart rate and blood pressure
  • Diabetes: Be aware of potential masking of hypoglycemia symptoms
  • Gastrointestinal disorders: Watch for exacerbation of symptoms or complications

How should Pro-Banthine therapy be adjusted for patients with multiple health conditions? A personalized approach, considering all comorbidities and potential drug interactions, is essential. Regular follow-ups and open communication with healthcare providers are key to optimizing treatment in these complex cases.

Managing Pro-Banthine Overdose: Recognizing and Responding

While rare, Pro-Banthine overdose can occur and requires prompt medical attention. Symptoms of overdose may include:

  • Severe dry mouth and thirst
  • Blurred vision or dilated pupils
  • Difficulty urinating
  • Severe constipation
  • Rapid heartbeat
  • Confusion or agitation
  • Hallucinations
  • Hyperthermia

What should you do if you suspect a Pro-Banthine overdose? Immediately contact emergency medical services or your local poison control center. Treatment may involve:

  1. Activated charcoal administration (if the overdose was recent)
  2. Supportive care to manage symptoms
  3. Physostigmine as an antidote in severe cases
  4. Close monitoring of vital signs and organ function

Prevention of Overdose

To minimize the risk of Pro-Banthine overdose:

  • Always follow prescribed dosage instructions
  • Keep medication out of reach of children
  • Use pill organizers to avoid double dosing
  • Be aware of potential drug interactions that may increase anticholinergic effects

Future Perspectives: Advances in Anticholinergic Therapy

As medical research progresses, new developments in anticholinergic therapy may offer improved options for conditions currently treated with Pro-Banthine:

Targeted Drug Delivery

Researchers are exploring ways to deliver anticholinergic medications more precisely to affected organs, potentially reducing systemic side effects. This could include:

  • Topical formulations for hyperhidrosis
  • Controlled-release preparations for gastrointestinal disorders
  • Intravesical delivery systems for overactive bladder

Novel Anticholinergic Agents

New compounds are being developed with the aim of providing more selective anticholinergic effects, potentially offering improved efficacy and reduced side effects compared to traditional agents like Pro-Banthine.

Combination Therapies

Researchers are investigating the potential benefits of combining anticholinergics with other classes of medications to enhance therapeutic effects while minimizing adverse reactions.

What potential advantages might these new approaches offer over current Pro-Banthine therapy? While it’s too early to say definitively, these advancements could potentially lead to more targeted treatments with fewer side effects and improved patient outcomes. However, extensive clinical trials will be necessary to establish the safety and efficacy of these new approaches.

As research in this field continues, patients and healthcare providers should stay informed about emerging treatment options that may offer alternatives or improvements to current Pro-Banthine therapy.

Pro Banthine (propantheline) dosing, indications, interactions, adverse effects, and more

  • abobotulinumtoxinA

    abobotulinumtoxinA increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Use of anticholinergic drugs after administration of botulinum toxin-containing products may potentiate systemic anticholinergic effects. .

  • aclidinium

    propantheline and aclidinium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • amantadine

    propantheline, amantadine. Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Potential for increased anticholinergic adverse effects.

  • amitriptyline

    propantheline and amitriptyline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • amoxapine

    propantheline and amoxapine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • anticholinergic/sedative combos

    anticholinergic/sedative combos and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • aripiprazole

    propantheline decreases levels of aripiprazole by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of aripiprazole by pharmacodynamic antagonism. Use Caution/Monitor.

    aripiprazole increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • atracurium

    atracurium and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • atropine

    atropine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • atropine IV/IM

    atropine IV/IM and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • belladonna alkaloids

    belladonna alkaloids and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • belladonna and opium

    belladonna and opium and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • benperidol

    propantheline decreases levels of benperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of benperidol by pharmacodynamic antagonism. Use Caution/Monitor.

    benperidol increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • benztropine

    benztropine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor. Additive anticholinergic adverse effects may be seen with concurrent use.

  • bethanechol

    bethanechol increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • buprenorphine, long-acting injection

    buprenorphine, long-acting injection increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Coadministration of buprenorphine with anticholinergic drugs may increase risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • carbachol

    carbachol increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • cevimeline

    cevimeline increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • chlorpromazine

    propantheline decreases levels of chlorpromazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of chlorpromazine by pharmacodynamic antagonism. Use Caution/Monitor.

    chlorpromazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • cisatracurium

    cisatracurium and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • clomipramine

    propantheline and clomipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • clozapine

    propantheline decreases levels of clozapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of clozapine by pharmacodynamic antagonism. Use Caution/Monitor.

    clozapine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • cyclizine

    cyclizine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • cyclobenzaprine

    cyclobenzaprine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • darifenacin

    darifenacin and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • desipramine

    propantheline and desipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • dicyclomine

    dicyclomine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • digoxin

    propantheline will increase the level or effect of digoxin by unspecified interaction mechanism. Modify Therapy/Monitor Closely. Measure serum digoxin concentrations before initiating concomitant drugs; reduce digoxin dose by approximately 15% to 30% or by modifying dosing frequency and continue monitoring

  • diphenhydramine

    diphenhydramine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • donepezil

    donepezil increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • donepezil transdermal

    donepezil transdermal, propantheline.
    Either decreases effects of the other by pharmacodynamic antagonism. Use Caution/Monitor.

  • dosulepin

    propantheline and dosulepin both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • doxepin

    propantheline and doxepin both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • droperidol

    propantheline decreases levels of droperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of droperidol by pharmacodynamic antagonism. Use Caution/Monitor.

    droperidol increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • echothiophate iodide

    echothiophate iodide increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • fesoterodine

    fesoterodine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • flavoxate

    flavoxate and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • fluphenazine

    propantheline decreases levels of fluphenazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of fluphenazine by pharmacodynamic antagonism. Use Caution/Monitor.

    fluphenazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • galantamine

    galantamine increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • glycopyrrolate

    glycopyrrolate and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • glycopyrrolate inhaled

    glycopyrrolate inhaled and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • haloperidol

    propantheline decreases levels of haloperidol by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of haloperidol by pharmacodynamic antagonism. Use Caution/Monitor.

    haloperidol increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • henbane

    henbane and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • homatropine

    homatropine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • huperzine A

    huperzine A increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • hyoscyamine

    hyoscyamine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • hyoscyamine spray

    hyoscyamine spray and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • iloperidone

    propantheline decreases levels of iloperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of iloperidone by pharmacodynamic antagonism. Use Caution/Monitor.

    iloperidone increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • imipramine

    propantheline and imipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • ipratropium

    ipratropium and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor. Due to the poor systemic absorption of ipratropium, interaction unlikely at regularly recommended dosages.

  • levodopa

    propantheline, levodopa. Other (see comment). Use Caution/Monitor.
    Comment: Anticholinergic agents may enhance the therapeutic effects of levodopa; however, anticholinergic agents can exacerbate tardive dyskinesia. In high dosage, anticholinergics may decrease the effects of levodopa by delaying its GI absorption. .

  • lofepramine

    propantheline and lofepramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • loxapine

    propantheline decreases levels of loxapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of loxapine by pharmacodynamic antagonism. Use Caution/Monitor.

    loxapine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • loxapine inhaled

    loxapine inhaled increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

    propantheline decreases levels of loxapine inhaled by pharmacodynamic antagonism. Use Caution/Monitor.

  • maprotiline

    propantheline and maprotiline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • meclizine

    meclizine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • methscopolamine

    methscopolamine and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • metoclopramide intranasal

    propantheline will decrease the level or effect of metoclopramide intranasal by Other (see comment). Use Caution/Monitor. Coadministration of metoclopramide intranasal with drugs that impair GI motility may decrease systemic absorption of metoclopramide. Monitor for reduced therapeutic effect.

  • neostigmine

    neostigmine increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • nortriptyline

    propantheline and nortriptyline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • olanzapine

    propantheline decreases levels of olanzapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of olanzapine by pharmacodynamic antagonism. Use Caution/Monitor.

    olanzapine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • oliceridine

    propantheline increases toxicity of oliceridine by Other (see comment). Use Caution/Monitor.
    Comment: Anticholinergic drugs may increase risk of urinary retention and/or severe constipation, which may lead to paralytic ileus. Monitor for signs of urinary retention or reduced gastric motility if oliceridine is coadministered with anticholinergics.

  • onabotulinumtoxinA

    onabotulinumtoxinA and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • orphenadrine

    propantheline and orphenadrine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • oxybutynin

    oxybutynin and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • oxybutynin topical

    oxybutynin topical and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • oxybutynin transdermal

    oxybutynin transdermal and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • paliperidone

    propantheline decreases levels of paliperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of paliperidone by pharmacodynamic antagonism. Use Caution/Monitor.

    paliperidone increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • pancuronium

    pancuronium and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • perphenazine

    propantheline decreases levels of perphenazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of perphenazine by pharmacodynamic antagonism. Use Caution/Monitor.

    perphenazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • physostigmine

    physostigmine increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • pilocarpine

    pilocarpine increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • pimozide

    propantheline decreases levels of pimozide by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of pimozide by pharmacodynamic antagonism. Use Caution/Monitor.

    pimozide increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • prabotulinumtoxinA

    propantheline, prabotulinumtoxinA.
    Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Use of anticholinergic drugs after administration of botulinum toxin-containing products may potentiate systemic anticholinergic effects.

  • pralidoxime

    pralidoxime and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • prochlorperazine

    propantheline decreases levels of prochlorperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of prochlorperazine by pharmacodynamic antagonism. Use Caution/Monitor.

    prochlorperazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • promethazine

    propantheline decreases levels of promethazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of promethazine by pharmacodynamic antagonism. Use Caution/Monitor.

    promethazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • protriptyline

    propantheline and protriptyline both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • pyridostigmine

    pyridostigmine increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • quetiapine

    propantheline decreases levels of quetiapine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of quetiapine by pharmacodynamic antagonism. Use Caution/Monitor.

    quetiapine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • rapacuronium

    propantheline and rapacuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • risperidone

    propantheline decreases levels of risperidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of risperidone by pharmacodynamic antagonism. Use Caution/Monitor.

    risperidone increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • rocuronium

    propantheline and rocuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • scopolamine

    propantheline and scopolamine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • solifenacin

    propantheline and solifenacin both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • succinylcholine

    succinylcholine increases and propantheline decreases cholinergic effects/transmission. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • thioridazine

    propantheline decreases levels of thioridazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of thioridazine by pharmacodynamic antagonism. Use Caution/Monitor.

    thioridazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • thiothixene

    propantheline decreases levels of thiothixene by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of thiothixene by pharmacodynamic antagonism. Use Caution/Monitor.

    thiothixene increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • tiotropium

    propantheline and tiotropium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • tolterodine

    propantheline and tolterodine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • trazodone

    propantheline and trazodone both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • trifluoperazine

    propantheline decreases levels of trifluoperazine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of trifluoperazine by pharmacodynamic antagonism. Use Caution/Monitor.

    trifluoperazine increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • trihexyphenidyl

    propantheline and trihexyphenidyl both decrease cholinergic effects/transmission. Use Caution/Monitor. Potential for additive anticholinergic effects.

  • trimipramine

    propantheline and trimipramine both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • trospium chloride

    propantheline and trospium chloride both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • umeclidinium bromide

    umeclidinium bromide and propantheline both decrease cholinergic effects/transmission. Use Caution/Monitor. If possible, avoid coadministration of additional anticholinergic agents

  • vecuronium

    propantheline and vecuronium both decrease cholinergic effects/transmission. Use Caution/Monitor.

  • ziprasidone

    propantheline decreases levels of ziprasidone by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of ziprasidone by pharmacodynamic antagonism. Use Caution/Monitor.

    ziprasidone increases effects of propantheline by pharmacodynamic synergism. Use Caution/Monitor. Additive anticholinergic effects, possible hypoglycemia.

  • zotepine

    propantheline decreases levels of zotepine by inhibition of GI absorption. Applies only to oral form of both agents. Use Caution/Monitor.

    propantheline decreases levels of zotepine by pharmacodynamic antagonism. Use Caution/Monitor.

  • Propantheline: MedlinePlus Drug Information


    pronounced as (proe pan’ the leen)

    To use the sharing features on this page, please enable JavaScript.

    • Why is this medication prescribed?
    • How should this medicine be used?
    • Other uses for this medicine
    • What special precautions should I follow?
    • What special dietary instructions should I follow?
    • What should I do if I forget a dose?
    • What side effects can this medication cause?
    • What should I know about storage and disposal of this medication?
    • In case of emergency/overdose
    • What other information should I know?
    • Brand names

    Propantheline is used with other medication to treat ulcers. Propantheline is in a class of medications called anticholinergics. It works by slowing the movement of food through the stomach and intestines and decreasing the amount of acid made by the stomach.

    Propantheline comes as a tablet to take by mouth. Propantheline is usually taken four times a day, 30 minutes before meals and at bedtime. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take propantheline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

    This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

    Before taking propantheline,

    • tell your doctor and pharmacist if you are allergic to propantheline, any other medications, or any of the ingredients in propantheline tablets. Ask your pharmacist for a list of the ingredients.
    • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements,and herbal products you are taking or plan to take. Be sure to mention any of the following: amantadine (Symmetrel), antihistamines, digoxin (Lanoxin), disopyramide (Norpace), glutethimide (Doriden), levodopa (Larodopa, Sinemet), meperidine (Demerol), extended-release potassium chloride tablets, quinidine (Quinaglute), tranquilizers, and medications for depression and Parkinson’s disease. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
    • tell your doctor if you have or have ever had colitis; glaucoma; an enlarged prostate gland; high blood pressure; an overactive thyroid gland; liver, heart, blood vessel, or kidney disease; myasthenia gravis; difficulty urinating; or asthma, bronchitis, emphysema, or lung disease.
    • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking propantheline, call your doctor.
    • talk to your doctor about the risks and benefits of taking propantheline if you are 65 years of age or older. Older adults should not usually take propantheline because it is not as safe or effective as other medications that can be used to treat the same condition.
    • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking propantheline.
    • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
    • ask your doctor about the safe use of alcohol while you are taking this medication. Alcohol can make the side effects of propantheline worse.

    Unless your doctor tells you otherwise, continue your normal diet.

    Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

    Propantheline may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dry mouth
    • increased sensitivity of your eyes to light
    • dizziness
    • nervousness
    • difficulty sleeping
    • headache
    • loss of sense of taste
    • upset stomach
    • vomiting
    • bloating
    • confusion (especially in the elderly)
    • blurred vision
    • constipation

    Some side effects can be serious.

    If you experience any of the following symptoms, call your doctor immediately:

    • fast heartbeat
    • heart palpitations
    • eye pain
    • difficulty urinating
    • skin rash
    • itching

    Propantheline may cause other side effects. Call your doctor if you have any unusual problems while you are taking propantheline.

    If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

    Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

    It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

    Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA’s Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

    In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can’t be awakened, immediately call emergency services at 911.

    • Pro-Banthine®

    Last Revised – 09/15/2017

    Browse Drugs and Medicines

    Antibacterial preparation for animals KRKA Cladaxa, 50 mg

    COMPOSITION AND PROPERTIES

    Tetracyclines are broad-spectrum bacteriostatic antibiotics that affect gram-positive and gram-negative bacteria, including anaerobes, rickettsiae, chlamydia, mycoplasmas and some protozoa. Tetracyclines are effective because they bind to the 30S subunit of the ribosome and block the attachment of aminoacyl-tRNA to the A-center of mRNA ribosomes. Thus, preventing the addition of new amino acids, disrupting the elongation of the polypeptide chain by inhibiting the protein synthesis of bacterial cells.
    Pharmacokinetics: Approximately 95% of doxycycline is completely absorbed after oral administration and, due to its high level of lipid solubility, it penetrates into most liquids and organic tissues. It binds well to plasma protein compared to other tetracyclines, resulting in a prolonged half-life in humans and animals. Doxycycline is excreted in the feces, not through the biliary tract, in an inactive form. Excretion from the body will be longer due to stable serum levels. Unlike other antimicrobials in its class, the presence of food in the gut will not affect the absorption of doxycycline.

    HOW TO USE

    Doxyphin tablets must be given to the animal in accordance with the recommended dose for a specific weight, from the hands of the owner, not mixed with other food or supplements, there is no need to pre-diet the animal or change the diet.

    DOSAGE

    Doxifin Tabs in tablets has three different forms of release, the tablets are dosed according to the weight of the animal. The therapeutic dosage of doxycycline is 10 mg/kg body weight once a day for 7 consecutive days, or in the treatment of ehrlichiosis for 28 consecutive days, or at the discretion of the veterinarian.

    APPLICATION

    The tablet must be cut in half along the groove along the tablet. To reduce the likelihood of a recurrence of ehrlichiosis, a veterinarian visit is required during and after treatment. However, the possibility of re-infection as a result of re-infection through contact with vector ticks must be considered, and prophylaxis against re-infection should be considered.

    SAFETY PRECAUTIONS

    Follow recommended dosage and dosage regimens. Only a veterinarian can make changes to the recommended dosages when using the drug. Unlike other tetracyclines, doxycycline is not a nephrotoxic substance and can be used in animals with chronic kidney disease and aging animals. For dogs and cats with severe liver disease, doxycycline should be used with extreme caution. In humans, neurotoxicity (benign intracranial hypertension) has been identified when taken with vitamin A, as well as the possibility of lupus erythematosus. Tetracyclines have been reported to alter the normal distribution of microorganisms in the digestive system.
    In cats, tablets are given with 5-6 ml of water (via syringe) or with food to avoid side effects from the administration of this drug (damage to the esophagus).

    Contraindications and restrictions on use:
    – Do not administer to animals with a history of hypersensitivity to doxycycline.
    – Do not give to pregnant or lactating animals.
    – Do not give to puppies and kittens less than thirty (30) days of age.

    SIDE EFFECTS

    The results of a clinical study confirmed the safety of the product at the indicated dosage once a day for 30 days in dogs and cats over 1 year of age.
    The safety of the drug has not been evaluated in elderly animals and animals during the mating period.
    Tetracyclines chelate calcium phosphorus in teeth and bones, penetrate structures, delay calcification, and can lead to hypoplasia of tooth enamel, staining it yellow and then brown. Despite the lower level of chelating compound with doxycycline, it is not recommended to use the drug in animals during the period of development and growth of teeth. According to reports from studies, the most common side effects are nausea, vomiting, hypersensitivity, slight drug photosensitivity. Cats were found to have narrowing of the esophagus, fever, and depression.

    Interaction with other drugs:
    Iron, aluminium, calcium, zinc, manganese reduce the serum concentration and bioavailability of tetracyclines as a result of their ability to form chelates with metal ions. Doxycycline has a rather low affinity for calcium ions, however, it is recommended to take a 1-2 hour break before or after the administration of tetracycline with these drugs. Tetracyclines may decrease plasma prothrombin activity, and dosage adjustments may be required in animals treated with anticoagulants. Concomitant administration of tetracycline with theophylline may worsen gastrointestinal side effects. The presence of h3 antihistamines may reduce the absorption of tetracyclines. Tetracyclines should not be used in conjunction with penicillin and cephalosporin due to the weakening of the bactericidal action of penicillins.
    Antacids can reduce the bioavailability of doxycycline by 85%. In this case, the interval between the introduction of these drugs should be 2 hours or more. Inducers of microsomal oxidation enzymes, such as phenobarbital and phenytoin, reduce the plasma concentration of doxycycline.
    B-complex vitamins, iron preparations, antacids and kaolin reduce the activity of tetracyclines.

    Presentation:
    – Doxyfin tablets 50 mg: Packs containing 1 blister with 14 tablets of 250 mg.
    – Doxifin tablets 100 mg: Packs containing 1 blister with 14 tablets of 500 mg.
    – Doxifin tablets 200 mg: Packs containing 2 blisters with 7 tablets of 1000 mg.

    STORAGE

    Store in original packaging in a cool, dry place at 15-30°C. Avoid direct sunlight, keep away from children and animals.
    The medicine is taken under the supervision of a veterinarian.

    Drugs with unusual side effects / Science hit

    As a rule, having received a prescription from a doctor, the patient goes to the pharmacy and buys the drug. Most often, people are interested in when and in what quantities they need to take the medicine, and almost no one pays attention to the item in which all side effects are prescribed.
    Compounds of chemicals in each individual drug, when interacting with the human body, can cause not only nausea or dizziness, but also other, extremely unusual sensations.

    I have compiled a list of drugs that can provoke the most strange reactions in the body.

    Capecitabine. No fingerprints
    A few years ago, a man who came from Singapore was detained in America. The tourist got to the station for one simple reason: the police could not get fingerprints from him. As it turned out later, the man took the drug, which in rare cases leads to a change in the skin of the hands and feet, up to the disappearance of fingerprints. As practice shows, after stopping this medication, the skin is restored.

    Ropinirole. Craving for gambling and intimacy
    GlaxoSmithKline, the manufacturer of this product, warns customers of all possible side effects. In 2011, a French resident sued drug manufacturers because he began to feel attracted to males and lost control of himself during gambling. Now on the insert for the tablets you can read all the warnings regarding cravings for games and intimacy.

    Amitriptyline. Blue staining of urine
    A person who is accustomed to the yellow color of urine will obviously be surprised when one day it changes color to blue. The fact is that the chemical composition of the shells of some drugs includes dyes that can provoke a change in the color of biological fluids in the body. These drugs also include the anesthetic indomethacin and the anesthetic propofol.

    Zolpidem. Desire to eat or cook while sleeping
    Many patients who tried the drug began to worry about their safety. The fact is that there have been several cases of driving a car in a state of increased drowsiness. In addition, several people have noted strange symptoms such as a strong desire to eat or cook food while sleeping.

    Voriconazole. Auditory and visual hallucinations
    In 2004, the journal Infection published an article about the antifungal drug voriconazole. The man who used the medicine claimed to have “heard” popular songs for five days in complete silence. A year later, an article appeared in another magazine stating that 12 people who took the drug had visual hallucinations.

    Vazoket. Inability to smell
    This drug, like many others, has a wide range of side effects. There may be problems with all five senses. However, the most strange thing can be called a change in smell. A side effect can manifest itself in both minor deviations and in the complete inability of a person to smell.

    Clomipramine. Irresistible desire to yawn and involuntary orgasm
    The drug, aimed at the treatment of depression and numerous phobias, helps to increase the concentration of the neurotransmitter serotonin in the brain. Patients taking this medicine often cannot control certain processes. For example, throughout the day a person feels an irresistible desire to yawn, even if he does not want to sleep and is not tired.